Assessing the association between dipeptidyl peptidase-4 inhibitors use and celiac disease through drug adverse event reporting.

Li, Dandan; Silvester, Jocelyn Anne; Crowley, Matthew J; Yang, Jeff Y; Alexopoulos, Anastasia-Stefania; Xu, Yang; Zhan, Siyan; Wang, Tiansheng

Li, Dandan; Silvester, Jocelyn Anne; Crowley, Matthew J; Yang, Jeff Y; Alexopoulos, Anastasia-Stefania; Xu, Yang; Zhan, Siyan; Wang, Tiansheng.

Afiliação

Li D; Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Silvester JA; Harvard Celiac Disease Research Program, Division of Gastroenterology, Hepatology & Nutrition, Boston Children's Hospital, Boston, MA, USA.
Crowley MJ; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
Yang JY; Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC, USA.
Alexopoulos AS; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
Xu Y; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
Zhan S; Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
Wang T; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, 2101 McGavran-Greenberg Hall, Campus Box 7453, 27599 Chapel Hill, NC 27515, USA.

Ther Adv Chronic Dis ; 11: 2040622320904301, 2020.

Article em En | MEDLINE | ID: mdl-32071711

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Ther Adv Chronic Dis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google